首页> 外文期刊>The Journal of cardiovascular nursing >Occurrence and extent of bruising according to duration of administration of subcutaneous low-molecular-weight heparin: A quasi-experimental case-crossover study
【24h】

Occurrence and extent of bruising according to duration of administration of subcutaneous low-molecular-weight heparin: A quasi-experimental case-crossover study

机译:皮下注射低分子量肝素的持续时间不同,瘀伤的发生和程度:一项准实验性病例交叉研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Several authors have documented the role of low-molecular-weight heparin injection techniques in bruising. However, few researchers have measured the influence of injection duration on the occurrence and extent of bruising. Purpose: The aim of this study was to evaluate the influence of different durations of subcutaneous heparin injection on the occurrence and extent of bruising. Methods: A quasi-experimental case-crossover study design was adopted in 2010. A consecutive series of patients admitted to 2 orthopedic units in a large (600 beds) teaching hospital located in northern Italy were eligible for enrolment. Injections were administered following a standard procedure. The manipulated variable was the duration of the injection, 10 seconds (treatment A) and 30 seconds (treatment B). The evaluation of bruise occurrence and extension performed after 48 hours and data analysis were conducted in a blinded fashion. Results: A total of 150 patients receiving their first and second subcutaneous heparin injections (300 injections) were enrolled. Eighty-seven bruises were observed out of 300 injections (29%): 57 of 150 (38%) after injections lasting 10 seconds and 30 of 150 (20%) after injections lasting 30 seconds (relative risk, 1.50; 95% confidence interval, 1.21-1.86; P = .00). Of the 87 bruises that occurred, 69 (79.3%) were small (2-5 mm) and 18 (20.6%) were large (>5 mm), with no difference in size between 10-and 30-second injections (relative risk, 0.91; 95% confidence interval, 0.39-2.12; P = .83). Conclusions: Low-molecular-weight heparin injection should be administered over 30 seconds to decrease bruising. Clinical Implications: There is a need to reflect on the feasibility of such a practice because injecting low-molecular-weight heparin at 30 seconds requires accuracy, a steady hand, the absence of tremor, a calm environment, and the ability to administer an infinitesimally small amount of liquid (eg, 0.4 mL) per second.
机译:背景:几位作者已经记录了低分子量肝素注射技术在瘀伤中的作用。但是,很少有研究者测量注射持续时间对青紫的发生和程度的影响。目的:本研究的目的是评估皮下注射肝素的不同持续时间对青紫的发生和程度的影响。方法:2010年采用准实验病例交叉研究设计。在意大利北部一家大型(600张病床)教学医院中,接受2个骨科治疗的连续系列患者符合入组条件。按照标准程序进行注射。受控变量是注射持续时间,10秒(治疗A)和30秒(治疗B)。 48小时后评估瘀伤的发生和扩展,以盲法进行数据分析。结果:总共有150名患者接受了第一次和第二次皮下肝素注射(300次注射)。在300次注射中观察到八十七处瘀伤(29%):注射持续10秒后有57处受伤(150%(38%)),注射持续30秒后有150处30%(20%)(相对风险,1.50; 95%置信区间,1.21-1.86; P = 0.00)。在发生的87处瘀伤中,有69处(79.3%)较小(2-5毫米),有18处(20.6%)较大(> 5毫米),注射10秒和30秒之间的大小无差异(相对危险) ,0.91; 95%置信区间:0.39-2.12; P = 0.83)。结论:低分子量肝素注射应在30秒内进行以减少瘀伤。临床意义:有必要反思这种做法的可行性,因为在30秒内注射低分子量肝素需要准确,稳定的手,没有震颤,安静的环境以及无限模拟给药的能力。每秒少量的液体(例如0.4 mL)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号